Warning! GuruFocus detected
1 Severe warning sign
with 0A05.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Medacta Group SA
ISIN : CH0468525222
Share Class Description:
LTS:0A05: Ordinary SharesDescription
Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.64 | |||||
| Debt-to-EBITDA | 1.48 | |||||
| Interest Coverage | 11.85 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.65 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.5 | |||||
| 3-Year EBITDA Growth Rate | 13.4 | |||||
| 3-Year EPS without NRI Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | 14.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 15.03 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.03 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.57 | |||||
| 9-Day RSI | 27.35 | |||||
| 14-Day RSI | 31.44 | |||||
| 3-1 Month Momentum % | 15.37 | |||||
| 6-1 Month Momentum % | 5.18 | |||||
| 12-1 Month Momentum % | 8.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 427.64 | |||||
| Days Sales Outstanding | 63.18 | |||||
| Days Payable | 75.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.48 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| Forward Dividend Yield % | 0.6 | |||||
| 5-Year Yield-on-Cost % | 0.48 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -0.23 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.65 | |||||
| Operating Margin % | 15.37 | |||||
| Net Margin % | 12.35 | |||||
| FCF Margin % | 0.34 | |||||
| ROE % | 20.8 | |||||
| ROA % | 9.88 | |||||
| ROIC % | 11.27 | |||||
| 3-Year ROIIC % | 6.35 | |||||
| ROC (Joel Greenblatt) % | 18.4 | |||||
| ROCE % | 16.43 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.66 | |||||
| Forward PE Ratio | 28.08 | |||||
| PE Ratio without NRI | 31.66 | |||||
| Shiller PE Ratio | 49.37 | |||||
| Price-to-Owner-Earnings | 33.08 | |||||
| PEG Ratio | 1.71 | |||||
| PS Ratio | 3.91 | |||||
| PB Ratio | 6.17 | |||||
| Price-to-Tangible-Book | 7.18 | |||||
| Price-to-Free-Cash-Flow | 1166.35 | |||||
| Price-to-Operating-Cash-Flow | 21.62 | |||||
| EV-to-EBIT | 26.5 | |||||
| EV-to-EBITDA | 15.75 | |||||
| EV-to-Revenue | 4.28 | |||||
| EV-to-FCF | 1296.39 | |||||
| Price-to-GF-Value | 0.74 | |||||
| Price-to-Projected-FCF | 6.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.68 | |||||
| Price-to-Graham-Number | 3.18 | |||||
| Earnings Yield (Greenblatt) % | 3.78 | |||||
| FCF Yield % | 0.08 | |||||
| Forward Rate of Return (Yacktman) % | 18.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medacta Group SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 559.599 | ||
| EPS (TTM) (CHF) | 3.462 | ||
| Beta | 1.55 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.2 | ||
| Volatility % | 26.19 | ||
| 14-Day RSI | 31.44 | ||
| 14-Day ATR (CHF) | 3.683197 | ||
| 20-Day SMA (CHF) | 124.90738 | ||
| 12-1 Month Momentum % | 8.68 | ||
| 52-Week Range (CHF) | 104.4 - 140.6 | ||
| Shares Outstanding (Mil) | 19.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medacta Group SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medacta Group SA Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medacta Group SA Frequently Asked Questions
What is Medacta Group SA(LTS:0A05)'s stock price today?
The current price of LTS:0A05 is CHF110.60. The 52 week high of LTS:0A05 is CHF140.60 and 52 week low is CHF104.40.
When is next earnings date of Medacta Group SA(LTS:0A05)?
The next earnings date of Medacta Group SA(LTS:0A05) is 2025-09-08.
Does Medacta Group SA(LTS:0A05) pay dividends? If so, how much?
The Dividend Yield %  of Medacta Group SA(LTS:0A05) is 0.48% (As of Today), Highest Dividend Payout Ratio of Medacta Group SA(LTS:0A05) was 0.22. The lowest was 0.12. And the median was 0.15. The  Forward Dividend Yield % of Medacta Group SA(LTS:0A05) is 0.6%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers